Department of Molecular Medicine, Aarhus University Hospital, DK-8000 Aarhus C, Denmark.
J Clin Endocrinol Metab. 2013 Jan;98(1):20-30. doi: 10.1210/jc.2012-2382. Epub 2012 Nov 1.
Recently, new clinically important information regarding Klinefelter syndrome (KS) has been published. We review aspects of epidemiology, endocrinology, metabolism, body composition, and neuropsychology with reference to recent genetic discoveries.
PubMed was searched for "Klinefelter," "Klinefelter's," and "XXY" in titles and abstracts. Relevant papers were obtained and reviewed, as well as other articles selected by the authors.
KS is the most common sex chromosome disorder in males, affecting one in 660 men. The genetic background is the extra X-chromosome, which may be inherited from either parent. Most genes from the extra X undergo inactivation, but some escape and serve as the putative genetic cause of the syndrome. KS is severely underdiagnosed or is diagnosed late in life, roughly 25% are diagnosed, and the mean age of diagnosis is in the mid-30s. KS is associated with an increased morbidity resulting in loss of approximately 2 yr in life span with an increased mortality from many different diseases. The key findings in KS are small testes, hypergonadotropic hypogonadism, and cognitive impairment. The hypogonadism may lead to changes in body composition and a risk of developing metabolic syndrome and type 2 diabetes. The cognitive impairment is mainly in the area of language processing. Boys with KS are often in need of speech therapy, and many suffer from learning disability and may benefit from special education. Medical treatment is mainly testosterone replacement therapy to alleviate acute and long-term consequences of hypogonadism as well as treating or preventing the frequent comorbidity.
More emphasis should be placed on increasing the rate of diagnosis and generating evidence for timing and dose of testosterone replacement. Treatment of KS should be a multidisciplinary task including pediatricians, speech therapists, general practitioners, psychologists, infertility specialists, urologists, and endocrinologists.
最近,有关克莱恩费尔特综合征(KS)的新的临床重要信息已经发布。我们回顾了流行病学、内分泌学、代谢、身体成分和神经心理学方面的内容,并参考了最近的遗传发现。
在标题和摘要中搜索了“Klinefelter”、“Klinefelter's”和“XXY”的 PubMed。获取并审查了相关论文,以及作者选择的其他文章。
KS 是男性最常见的性染色体疾病,影响每 660 名男性中的 1 名。遗传背景是额外的 X 染色体,它可能来自父母中的任何一方。额外 X 染色体上的大多数基因都会失活,但有些基因会逃脱,并被认为是该综合征的潜在遗传原因。KS 严重漏诊或在生命后期才被诊断出来,约有 25%被诊断出来,诊断的平均年龄在 30 多岁。KS 与发病率增加有关,导致寿命缩短约 2 年,并且由于多种不同的疾病而导致死亡率增加。KS 的主要发现是睾丸小、促性腺激素性性腺功能减退和认知障碍。性腺功能减退可能导致身体成分发生变化,并增加发生代谢综合征和 2 型糖尿病的风险。认知障碍主要在语言处理方面。KS 男孩通常需要言语治疗,许多人患有学习障碍,可能受益于特殊教育。医疗主要是睾丸激素替代疗法,以缓解性腺功能减退的急性和长期后果,以及治疗或预防常见的合并症。
应该更加重视提高诊断率,并为睾丸激素替代的时间和剂量提供证据。KS 的治疗应该是一个多学科的任务,包括儿科医生、言语治疗师、全科医生、心理学家、不孕专家、泌尿科医生和内分泌科医生。